1. Tranexamic versus aminocaproic acids in patients with total hip arthroplasty: a retrospective study
- Author
-
Hui Xie, Yu-Shen Yang, Si-miao Tian, Ben-jie Wang, Wei-min Fu, Liang-liang Cheng, Nan-nan Jiang, Guishan Gu, and De-wei Zhao
- Subjects
Total hip arthroplasty ,Transfusion ,Tranexamic acid ,Epsilon aminocaproic acid ,Cost savings ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Abstract Background Recently, tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) have been applied in total hip arthroplasty (THA). However, doubts in clinicians’ minds about which medicine is more efficient and economical in THA need to be clarified. Therefore, this study compared the efficacy and cost of the intraoperative administration of TXA and EACA per surgery in decreasing perioperative blood transfusion rates in THA. Methods This study enrolled patients who underwent THA between January 2019 to December 2020. A total of 295 patients were retrospectively divided to receive topical combined with intravenous TXA (n = 94), EACA (n = 97) or control (n = 104). The primary endpoints included transfusions, estimated perioperative blood loss, cost per patient and the drop in the haemoglobin and haematocrit levels. Results Patients who received EACA had greater total blood loss, blood transfusion rates, changes in HGB levels and mean cost of blood transfusion per patient (P
- Published
- 2022
- Full Text
- View/download PDF